We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,260 results
  1. A toxic gain-of-function mechanism in C9orf72 ALS impairs the autophagy-lysosome pathway in neurons

    Background

    Motor neurons (MNs), which are primarily affected in amyotrophic lateral sclerosis (ALS), are a specialized type of neurons that are long...

    Jimmy Beckers, Arun Kumar Tharkeshwar, ... Philip Van Damme in Acta Neuropathologica Communications
    Article Open access 18 September 2023
  2. C9orf72-Associated Dipeptide Repeat Expansions Perturb ER-Golgi Vesicular Trafficking, Inducing Golgi Fragmentation and ER Stress, in ALS/FTD

    Hexanucleotide repeat expansions (HREs) in the chromosome 9 open reading frame 72 ( C9orf72 ) gene are the most frequent genetic cause of amyotrophic...

    Jessica Sultana, Audrey M. G. Ragagnin, ... Julie D. Atkin in Molecular Neurobiology
    Article Open access 09 May 2024
  3. Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that affects motor neurons, causing progressive muscle weakness and...

    Gabriela Toro Cabrera, Katharina E. Meijboom, ... Christian Mueller in Gene Therapy
    Article 26 September 2023
  4. C9ORF72 patient-derived endothelial cells drive blood-brain barrier disruption and contribute to neurotoxicity

    The blood-brain barrier (BBB) serves as a highly intricate and dynamic interface connecting the brain and the bloodstream, playing a vital role in...

    Ana Aragón-González, Allan C Shaw, ... Laura Ferraiuolo in Fluids and Barriers of the CNS
    Article Open access 11 April 2024
  5. PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons

    Dipeptide repeat proteins are a major pathogenic feature of C9orf72 amyotrophic lateral sclerosis (C9ALS)/frontotemporal dementia (FTD) pathology,...

    Carmelo Milioto, Mireia Carcolé, ... Adrian M. Isaacs in Nature Neuroscience
    Article Open access 29 February 2024
  6. Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder which is characterized by the loss of both upper and lower motor neurons in the...

    Zsófia Flóra Nagy, Margit Pál, ... Márta Széll in BMC Medical Genomics
    Article Open access 22 January 2024
  7. Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations

    Heterozygous mutations in the GRN gene and hexanucleotide repeat expansions in C9orf72 are the two most common genetic causes of Frontotemporal...

    Oana C. Marian, Jonathan D. Teo, ... Anthony S. Don in Acta Neuropathologica Communications
    Article Open access 27 March 2023
  8. Globally reduced N6-methyladenosine (m6A) in C9ORF72-ALS/FTD dysregulates RNA metabolism and contributes to neurodegeneration

    Repeat expansion in C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we show...

    Yini Li, **aoyang Dou, ... Shuying Sun in Nature Neuroscience
    Article 26 June 2023
  9. Senataxin helicase, the causal gene defect in ALS4, is a significant modifier of C9orf72 ALS G4C2 and arginine-containing dipeptide repeat toxicity

    Identifying genetic modifiers of familial amyotrophic lateral sclerosis (ALS) may reveal targets for therapeutic modulation with potential...

    Craig L. Bennett, Somasish Dastidar, ... Albert R. La Spada in Acta Neuropathologica Communications
    Article Open access 17 October 2023
  10. Involvement of striatal motoric subregions in familial frontotemporal dementia with parkinsonism harboring the C9orf72 repeat expansions

    The chromosome 9 open reading frame 72 (C9ORF72) has been proposed as the causative gene of frontotemporal dementia with parkinsonism (FTDP), but its...

    Li Liu, Shuying Liu, ... Liyong Wu in npj Parkinson's Disease
    Article Open access 06 October 2022
  11. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis

    Intronic G 4 C 2 hexanucleotide repeat expansions (HRE) of C9orf72 are the most common cause of familial variants of frontotemporal dementia/amyotrophic...

    Kyle J. Trageser, Eun-Jeong Yang, ... Giulio Maria Pasinetti in Molecular Neurobiology
    Article 03 April 2023
  12. Synaptic proteomics reveal distinct molecular signatures of cognitive change and C9ORF72 repeat expansion in the human ALS cortex

    Increasing evidence suggests synaptic dysfunction is a central and possibly triggering factor in Amyotrophic Lateral Sclerosis (ALS). Despite this,...

    Zsofia I. Laszlo, Nicole Hindley, ... Christopher M. Henstridge in Acta Neuropathologica Communications
    Article Open access 29 October 2022
  13. Repeat length of C9orf72-associated glycine–alanine polypeptides affects their toxicity

    G 4 C 2 hexanucleotide repeat expansions in a non-coding region of the C9orf72 gene are the most common cause of familial amyotrophic lateral sclerosis...

    Javier Morón-Oset, Lilly Katharina Sophie Fischer, ... Linda Partridge in Acta Neuropathologica Communications
    Article Open access 29 August 2023
  14. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

    Expansions of a G 4 C 2 repeat in the C9ORF72 gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia...

    Hélène Tran, Michael P. Moazami, ... Robert H. Brown Jr in Nature Medicine
    Article 23 December 2021
  15. Reduced mtDNA Copy Number in the Prefrontal Cortex of C9ORF72 Patients

    Hexanucleotide repeat expansion in C9ORF72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia...

    Maria Isabel Alvarez-Mora, Petar Podlesniy, ... Laia Rodriguez-Revenga in Molecular Neurobiology
    Article 03 January 2022
  16. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype

    Background

    Frontotemporal dementia (FTD) covers a spectrum of neurodegenerative disorders with various clinical and neuropathological subtypes. The...

    Kasper Katisko, Nadine Huber, ... Eino Solje in Alzheimer's Research & Therapy
    Article Open access 11 October 2022
  17. Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond

    The identification of C9orf72 gene has led to important scientific progresses and has considerably changed our clinical practice. However, a decade...
    Dario Saracino, Isabelle Le Ber in Frontotemporal Dementias
    Chapter 2021
  18. Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation

    The most common inherited cause of two genetically and clinico-pathologically overlap** neurodegenerative diseases, amyotrophic lateral sclerosis...

    Feilin Liu, Dmytro Morderer, ... Wilfried Rossoll in Acta Neuropathologica Communications
    Article Open access 14 February 2022
  19. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD

    The most common genetic cause of familial and sporadic amyotrophic lateral sclerosis (ALS) is a GGGGCC hexanucleotide repeat expansion (HRE) in the...

    Alyssa N. Coyne, Jeffrey D. Rothstein in Acta Neuropathologica Communications
    Article Open access 19 March 2021
  20. An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people

    Cognitive decline of aging is modulated by chronic inflammation and comorbidities. In people with HIV-infection (PWH) it may also be affected by...

    Isabella Zanella, Eliana Zacchi, ... Eugenia Quiros-Roldan in Metabolic Brain Disease
    Article Open access 30 March 2022
Did you find what you were looking for? Share feedback.